Last verified: April 2026
The December 2025 Federal Schedule III Executive Order
President Trump’s December 2025 executive order directed HHS to develop “models to improve access to hemp-derived cannabinoid products” alongside the Schedule III marijuana rescheduling pathway initiated under the previous administration. As of April 2026, Iowa GOP leaders have not changed their posture. Senate Majority Leader Jack Whitver and House Speaker Pat Grassley continue to cite federal Schedule I as the operative reason to wait. Whether the “wait for the feds” defense survives an actual finalization of Schedule III is the central open question for 2027.
Rescheduling alone does not federally legalize state recreational programs. But it would weaken the central rhetorical frame Iowa Republican leadership has used since 2017. It would also force Iowa pharmacy and medical-practice law to confront the gap between a Schedule III federal substance and Iowa’s Chapter 124E pharmacist-consultation framework.
The November 12, 2026 Federal Hemp Cliff (P.L. 119-37)
The November 2025 federal stopgap caps THC at 0.4 mg per container effective November 12, 2026. Industry analyses estimate roughly 95% of currently legal intoxicating hemp products nationally will become Schedule I marijuana federally on the effective date. Iowa’s already-restrictive HF 2605 (2024) framework will tighten further as a matter of federal law — on top of state retail enforcement.
For Iowa specifically, the hemp cliff means the consumable-hemp gray market that grew under SF 599 (2019) and was cut back under HF 2605 (2024) faces a final compression in late 2026. Hemp industry advocacy through the Iowa Hemp Association is likely to intensify around state-level alignment with the new federal definition.
The 2026 General Election
Iowa governor is not on the 2026 ballot — Gov. Reynolds was re-elected in 2022 and serves through January 2027 with eligibility for one more term. Iowa legislative seats are on the 2026 ballot: all 100 House seats and roughly half the 50 Senate seats stagger through every cycle. Both Iowa U.S. Senate seats (Sens. Chuck Grassley and Joni Ernst) are not on the 2026 ballot.
The legislative election is therefore the realistic 2026 lever. A flip of even one chamber, or a leadership change inside the Republican caucus, would alter the cannabis-bill committee dynamics described in key legislators. On current polling and partisan lean, neither flip is the base-case scenario.
The 2027 General Assembly Session
The 2027 session is the first opportunity for new committee leadership after the 2026 elections. House Health and Human Services, Senate Judiciary, and the floor-scheduling offices of the Speaker and Majority Leader all reorganize. If 2026 produces no flip but Speaker Grassley’s January 2026 Iowa Press hint — that his caucus may reconsider given border-state pressure — develops, 2027 is the session in which it would surface.
Sports-Betting Precedent
Iowa legalized sports betting in 2019 after revenue began flowing past borders to Illinois and other neighbors. Cannabis advocates point to the parallel: Iowa now captures roughly $70 million-plus per year in sports-betting tax revenue. The argument from Iowa Capital Dispatch analyses is that Iowa is forgoing $40–$50 million in potential annual cannabis tax revenue to its three legalized neighbors (Illinois, Minnesota, Missouri).
Approximately 60% of Iowans support adult-use legalization, per consistent Selzer & Co. polling cited by House Minority Leader Jennifer Konfrst (D-Windsor Heights). Iowa is one of 24 states without a citizen-initiated ballot-measure process, so the only path to legalization runs through the legislature.
Des Moines Register / Mediacom Iowa Poll, Selzer & Co.; University of Iowa Hawkeye Poll
Polling Trend
| Year | Source | Finding |
|---|---|---|
| 2021 | Iowa Poll (Selzer & Co. for Des Moines Register / Mediacom) | 54% support legalizing recreational marijuana |
| 2022 | University of Iowa Hawkeye Poll | 71% support medical cannabis; 52.5% adult-use |
| 2024–2025 | Selzer & Co. consistent polling | ~60% support adult-use legalization |
Source: Iowa Poll archive at Des Moines Register; University of Iowa Hawkeye Poll; House Minority Leader Konfrst legislative-session citations.
The Post-Caucus Political Landscape
Iowa was a presidential caucus state for both parties from 1972 through 2024. The Democratic National Committee moved the Iowa caucus from first-in-the-nation status starting 2024; the Iowa Republican caucus held its 2024 contest before continuing to lose its preeminent role. Pre-2024 cycles brought candidate-driven cannabis scrutiny — in 2020, Bernie Sanders, Elizabeth Warren, Kamala Harris, Cory Booker, and Andrew Yang all expressed support for federal cannabis legalization or descheduling on Iowa stages. That structural pressure has eased. Iowa cannabis policy is no longer routinely tested against a national-candidate field.
Possible Catalysts for Change
- Federal Schedule III actually finalizing. Would weaken the “wait for the feds” argument that has anchored Republican leadership’s position since 2017. Forces Iowa pharmacy law to align with federal scheduling.
- A budget shortfall large enough to make cross-river revenue capture politically attractive. The sports-betting precedent established the pattern: Iowa moves when revenue is visibly flowing to neighbors.
- A leadership change in the Senate or House. Whitver, Grassley, and Meyer are the operational gatekeepers; a change in any of those positions reshapes the bill calendar.
- A federal rescheduling that includes pharmaceutical-access changes. Would require Iowa to align state pharmacy law with the new federal regime, opening a vehicle for procedural reform.
Iowa’s Bordering-State Pressure (Status as of April 2026)
| Border State | Status | Key Date |
|---|---|---|
| Illinois | Adult-use retail | Jan 1, 2020 (over $750M Yr-1) |
| Missouri | Adult-use retail | Feb 2023 ($1.52B in 2025) |
| Minnesota | Adult-use; retail rolling out | Legalized 2023 |
| Nebraska | Medical approved (Nov 2024) | Rolling out 2025–26 |
| South Dakota | Medical operational; rec defeated 2024 | 2021 (medical) |
| Wisconsin | Prohibition (only Iowa peer) | — |
Source: respective state cannabis regulators; Iowa Capital Dispatch reporting on revenue impact.
Most Likely 2026–2030 Trajectory
Continued status quo. Republican legislative discipline, the Reynolds veto pen through January 2027, and the absence of a citizen-initiated ballot measure mean change requires one of the catalysts above. The Iowa Republican caucus has shown more willingness to pass restrictive hemp legislation (HF 2605, 2024) than to expand the medical program. Iowa Medical Cannabidiol Board recommendations — vaporizable raw flower, telemedicine certification, independent testing labs, federal waiver pursuit — remain unenacted.
The cumulative pressure from three legalized borders and roughly 60% adult-use support produces incremental program adjustments at most. The 4.5-gram-per-90-days THC cap, the five-dispensary cap, the smokable-flower prohibition, the §730.5 absence of patient employment protection, and the §321J zero-tolerance OWI metabolite rule are all expected to remain through the 2026 election cycle.
What to Watch Through 2027
- Spring 2026: HF 990 medical expansion bill subcommittee progress; SF 46 dispensary-cap bill Senate action.
- November 12, 2026: federal hemp cliff (P.L. 119-37) takes effect; Iowa Hemp Association response.
- November 2026: Iowa legislative election — House Speaker, Senate Majority Leader, and committee chair posts at stake.
- December 2026: federal Schedule III finalization status check.
- January 2027: 92nd General Assembly convenes; new committee leadership; first session after the 2026 election.
- 2028: Iowa governor next on ballot.
Explore Reform & Politics
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org